Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery.

Author: BrownR A, GraczykS G, HahneW F, HickokC B, KallarS, McKenzieR, MelsonT, MorrillB

Paper Details 
Original Abstract of the Article :
The newer 5-hydroxytryptamine type 3 (5-HT3) antagonists are sometimes considered for routine prophylaxis of postoperative nausea and vomiting (PONV) in high-risk patients. This multicenter, randomized, double-blind, placebo-controlled study compared the efficacy and safety of three single intraveno...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00000539-199702000-00015

データ提供:米国国立医学図書館(NLM)

Preventing Postoperative Nausea and Vomiting: The Role of Dolasetron

This research examines the efficacy and safety of dolasetron, a 5-hydroxytryptamine type 3 (5-HT3) antagonist, in preventing postoperative nausea and vomiting (PONV) in patients undergoing outpatient laparoscopic gynecologic surgery. The study aimed to assess the effectiveness of different doses of dolasetron administered intravenously in reducing the incidence and severity of PONV. The authors highlight the significant impact of PONV on patient recovery and satisfaction.

Dolasetron's Effectiveness: Reducing Nausea and Vomiting

The study demonstrates that dolasetron significantly reduced the incidence and severity of PONV in patients undergoing laparoscopic gynecologic surgery. The authors found that all three doses of dolasetron were effective, with higher doses associated with a greater proportion of patients experiencing complete relief from PONV. They also found that dolasetron was well-tolerated, with a low incidence of adverse events.

A Valuable Tool for Postoperative Recovery: Minimizing Discomfort

This research provides valuable insights into the use of dolasetron as a preventive measure for PONV. The study's findings support the use of dolasetron as a safe and effective treatment option, potentially enhancing patient recovery and satisfaction after laparoscopic gynecologic surgery.

Dr.Camel's Conclusion

This research is like a camel caravan traveling through a desert oasis, where a refreshing drink of dolasetron can help prevent the unpleasant side effects of a long journey. The study's findings suggest that dolasetron can make the postoperative recovery experience more comfortable and enjoyable for patients. This research reminds us that the journey towards good health can be made smoother with the right tools and interventions.
Date :
  1. Date Completed 1997-03-04
  2. Date Revised 2019-07-04
Further Info :

Pubmed ID

9024022

DOI: Digital Object Identifier

10.1097/00000539-199702000-00015

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.